September 2026
The stem cell therapy for neurological disorders market generated USD 17.90 billion in 2026, with prominent stem cell therapy for neurological disorders market companies including BrainStorm Cell Therapeutics, Mesoblast, ReNeuron Group.
July 2026
The stem cell therapy market size is expected to increase from USD 18.13 billion in 2025 and it is predicted to hit USD 59.70 billion by 2035 at a CAGR of 12.66%.
June 2026
The U.S. stem cell therapy market size reached USD 6.75 billion in 2025 and is projected to hit around USD 21.31 billion by 2035 with a remarkeble CAGR of 12.18%.
June 2026
The global induced pluripotent stem cell (iPSC) therapy market is driven by rising chronic disease prevalence, personalized medicine demand, and advances in regenerative technology.
December 2025
The global automated and closed cell therapy processing system market size is expected to hit around USD 14.46 billion by 2035 with a CAGR of 22.76%.
September 2026
The global stem cell banking market size was valued at USD 8.93 billion in 2026 and is expected to surpass around USD 27.71 billion by 2034 with a CAGR of 15.29%.
September 2026
The global personalized cell therapy market size was evaluated at USD 46.06 billion in 2026 and is predicted to reach around USD 235.65 billion by 2034, with a CAGR of 22.81%.
September 2026
The cell and gene therapy manufacturing market size is predicted to hit around USD 122.86 billion by 2034 from USD 18.06 billion in 2026, with a CAGR of 26.62%.
September 2026
The global cell and gene therapy bioanalytical testing services market size is expected to hit around USD 1,113.86 million by 2034 from USD 632.03 million in 2026, with a CAGR of 7.34%.
September 2026
The global stem cell manufacturing market size reached USD 17.57 billion in 2026 and is projected to surpass around USD 45.38 billion by 2035, with a solid CAGR of 11.13%.
September 2026
The global stem cells market surpassed USD 20.79 Bn in 2026 and is projected to cross USD 53.32 Bn by 2035, growing at a CAGR of 11.08% from 2026 to 2035.
September 2026
The synthetic stem cells market size stood at USD 11.25 billion in 2026, with major synthetic stem cells market companies including Brainstorm Cell Therapeutics, Fate Therapeutics, Evotec, Cesca Therapeutics, VistaGen Therapeutics.
September 2026
The automation, digitization and robotics in cell and gene therapy manufacturing market reached USD 1,127.65 million in 2026, with key automation, digitization and robotics in cell and gene therapy manufacturing market companies including Thermo Fisher Scientific Inc., Sartorius AG, Danaher Corporation (Cytiva), Lonza Group AG.
September 2026
The global large-scale active stem cell clinical trials market size was evaluated at USD 8.27 billion in 2026 and is predicted to hit around USD 28.88 billion by 2035, growing at a CAGR of 14.90%.
September 2026
The hematopoietic stem cell transplantation market size reached USD 12.69 billion in 2026, with leading hematopoietic stem cell transplantation market companies including Novartis, Gilead Sciences, Baxter International, Fresenius Kabi.
September 2026
The U.S. cell therapy manufacturing market was worth USD 1.97 billion in 2026, with key U.S. cell therapy manufacturing market players including Merck KGaA, Thermo Fisher Scientific, Catalent, Inc.
September 2026
The U.S. CAR T-cell therapy market size stood at USD 2,684.84 million in 2026, with major U.S. CAR T-cell therapy market companies including Bristol-Myers Squibb Company, Novartis AG, Gilead Sciences, Inc.
September 2026
The global cancer stem cells market size is anticipated to worth around USD 6.60 billion by 2034 from USD 2.69 billion in 2026 with a CAGR of 11.92%.
September 2026
The global induced pluripotent stem cells market size is estimated to hit around USD 5.57 billion by 2035, increasing from USD 2.13 billion in 2025, with a CAGR of 10.09%.
September 2026
The US cell and gene therapy market generated USD 4.74 billion in 2026, with prominent US cell and gene therapy market companies including Alnylam Pharmaceuticals Inc., Amgen Inc., Biogen Inc., CORESTEM Inc.
September 2026
The global stem cell transplantation market growth is driven by rising cancer cases, advances in regenerative medicine, and increasing stem cell research.
August 2026
The autologous stem cell and non-stem cell based therapies market size stood at USD 10.75 billion in 2026, with major autologous stem cell and non-stem cell based therapies market companies including Vericel Corporation, Holostem Terapie Avanzate, Anterogen Co. Ltd., BrainStorm Cell Therapeutics.
August 2026
The stem cell umbilical cord blood market size totalled USD 18.57 billion in 2025, with major stem cell umbilical cord blood market players including Cord Blood Registry (CBR), Cryo-Cell International, Inc., ViaCord (PerkinElmer), Global Cord Blood Corporation.
August 2026
The cell therapy market size reached USD 9.13 billion in 2026, with leading cell therapy market companies including cell therapy , Cells for Cells, Celgene Corporation.
August 2026
The global cell and gene therapy clinical trials market size is projected to hit around USD 54.29 billion by 2034 from USD 13.32 billion in 2024 with a CAGR of 15.09%
July 2026
The global image-guided therapy systems market size is projected to hit around USD 11.22 billion by 2035 from USD 6.47 billion in 2025 with a notable CAGR of 5.66%.
July 2026
The global CAR T-cell therapy market size is calculated at USD 5,206.15 million in 2025 and is projected to surpass around USD 26,982.3 million by 2035 with a solid CAGR of 17.88%.
July 2026
The cell and gene therapy market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
July 2026
The cell and gene therapy patient access and reimbursement market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries..
June 2026
The global engineered TCR (T-Cell Receptor) therapy market is growing as immunotherapies advance for cancer and infectious disease treatment.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com